Fax: (734) 936-2756
Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions
A report on 18 patients
Article first published online: 3 JAN 2003
Copyright © 2003 American Cancer Society
Volume 97, Issue 2, pages 499–507, 15 January 2003
How to Cite
Su, L. D., Fullen, D. R., Sondak, V. K., Johnson, T. M. and Lowe, L. (2003), Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions. Cancer, 97: 499–507. doi: 10.1002/cncr.11074
Fax: (734) 936-2756
- Issue published online: 3 JAN 2003
- Article first published online: 3 JAN 2003
- Manuscript Accepted: 5 SEP 2002
- Manuscript Revised: 26 AUG 2002
- Manuscript Received: 19 JUN 2002
- Spitz nevus;
- atypical Spitz tumor;
- spitzoid melanoma;
- sentinel lymph node
Spindle and/or epithelioid melanocytic proliferations that display overlapping histopathologic features of Spitz nevus and Spitz-like melanoma are diagnostically difficult and controversial melanocytic tumors. There are reports of such lesions metastasizing to regional lymph nodes, with a few widely disseminating, resulting in death.
The authors reviewed clinical and histopathologic data on all patients with atypical or borderline spitzoid melanocytic proliferations who underwent sentinel lymph node biopsy (SLNB). They examined how frequently histologically problematic or borderline spitzoid melanocytic lesions metastasized to sentinel lymph nodes (SLNs) and which clinical or histologic features, if any, predisposed patients to a higher risk lesion.
Six male patients and 12 female patients, ages 5–32 years (mean, 16 years), had tumors ranging in size from 1.2 mm to 7.9 mm (mean, 3.5 mm) in thickness. Atypical histologic features that were present most frequently included incomplete maturation (18 of 18 patients), deep dermal mitoses (16 of 18 patients), nuclear pleomorphism (10 of 18 patients), and focal sheet-like growth (10 of 18 patients). Eight of 18 patients (44%) had SLN metastasis and were offered adjuvant treatment. One of eight patients with SLN positive results who underwent regional lymphadenectomy had one additional involved lymph node. All 18 patients were alive and well with no evidence of recurrent or metastatic disease after a follow-up of 3–42 months (mean, 12 months).
Histologically atypical or borderline spitzoid, melanocytic tumors are diagnostically challenging and controversial melanocytic lesions, some of which represent unrecognized melanomas. SLNB aids in confirming a diagnosis of melanoma and identifies patients who may benefit from early therapeutic lymph node dissection and/or adjuvant therapy. Cancer 2003;97:499–507. © 2003 American Cancer Society.